United Kingdom Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

SUMMARY

Abstract

United Kingdom Ophthalmic Devices Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the UK ophthalmic devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the ophthalmic devices in UK

Scope

TABLE OF CONTENTS

Table of Contents

1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of the Markets Covered in the Report 11
3.1 Ophthalmic Devices 11
3.2 Cataract Surgery 11
3.2.1 Phacoemulsification Equipment 11
3.2.2 Intra Ocular Lens 11
3.3 Vision Care 11
3.3.1 Ophthalmoscopes 11
3.3.2 Contact lenses 11
3.3.3 Lens care 11
3.3.4 Ophthalmic lens 12
3.3.5 Rigid Gas Permeable Contact Lenses 12
3.4 Refractive Surgery 12
4 Healthcare Sector Review 13
4.1 Healthcare Expenditure 13
4.2 Healthcare Infrastructure 14
4.3 Healthcare Policy 16
5 Regulation System 17
5.1 Medical Equipment Approval Process 17
5.1.1 Classification of Medical Devices 17
5.1.2 Conformity Assessment Process 25
5.2 Medical Device approval fee 29
5.3 Post Market Surveillance (PMS) 30
6 Pricing and Reimbursement 31
6.1 Market Pricing 31
6.2 Government Policies for Reimbursement 31
7 Distribution Structure 33
8 United Kingdom Medical Equipment Cross Market Comparison 34
9 Ophthalmic Devices Cross Country Comparison 36
10 Ophthalmic Devices in United Kingdom 38
10.1 Ophthalmic Devices Overall Revenues by Category (2000-2012) 38
10.2 Ophthalmic Devices Overall Volume by Category (2000-2012) 42
10.3 Ophthalmic Devices Overall Company Share (2006-2007) 43
11 Vision Care in United Kingdom 44
11.1 Vision Care Revenues by Segment (2000-2012) 44
11.2 Vision Care Volume by Segment (2000-2012) 47
11.3 Vision Care Average Price (2000-2012) 48
11.4 Vision Care Distribution Share (2006-2007) 49
11.5 Vision Care Company Share (2006-2007) 50
12 Cataract Surgery in United Kingdom 51
12.1 Cataract Surgery Revenues by Segment (2000-2012) 51
12.2 Cataract Surgery Volume by Segment (2000-2012) 53
12.3 Cataract Surgery Average Price (2000-2012) 54
12.4 Cataract Surgery Distribution Share (2006-2007) 55
12.5 Cataract Surgery Company Share (2006-2007) 56
13 Refractive Surgery in United Kingdom 57
13.1 Refractive Surgery Revenues (2000-2012) 57
13.2 Refractive Surgery Volume (2000-2012) 59
13.3 Refractive Surgery Average Price (2000-2012) 61
13.4 Refractive Surgery Distribution Share (2006-2007) 62
13.5 Refractive Surgery Company Share (2006-2007) 63
14 Alcon, Inc. Company Profile 64
14.1 Company Overview 64
14.2 Value Chain Analysis 64
14.2.1 Manufacturing 65
14.2.2 Product Development 65
14.2.3 Sales and Marketing 66
14.3 Alcon, Inc. Pipeline Products 67
14.3.1 Alcon, Inc. Pipeline Products by Equipment Type 67
14.3.2 Alcon, Inc. Pipeline Products by Development Stage 67
14.3.3 Alcon, Inc. Pipeline Products by Therapy Area 67
14.3.4 Alcon, Inc. Pipeline Products by Clinical Trials 68
15 Altomed Ltd. Company Review 69
15.1 Company Overview 69
16 Bausch & Lomb Incorporated Company Profile 70
16.1 Company Overview 70
16.2 Value Chain Analysis 70
16.2.1 Manufacturing 71
16.2.2 Product Development 71
16.2.3 Sales and Marketing 72
16.3 Bausch & Lomb Incorporated Pipeline Products 73
16.3.1 Bausch & Lomb Incorporated Pipeline Products by Equipment Type 73
16.3.2 Bausch & Lomb Incorporated Pipeline Products by Development Stage 73
16.3.3 Bausch & Lomb Incorporated Pipeline Products by Therapy Area 73
16.3.4 Bausch & Lomb Incorporated Pipeline Products by Clinical Trials 74
16.3.5 Bausch & Lomb Incorporated Pipeline Products by News Summary 74
17 Carleton Limited Company Review 75
17.1 Company Overview 75
18 CIBA Vision Corporation Company Profile 76
18.1 Company Overview 76
18.2 CIBA Vision Corporation Pipeline Products 76
18.2.1 CIBA Vision Corporation Pipeline Products by Equipment Type 76
18.2.2 CIBA Vision Corporation Pipeline Products by Development Stage 76
18.2.3 CIBA Vision Corporation Pipeline Products by Therapy Area 76
18.2.4 CIBA Vision Corporation Pipeline Products by Clinical Trials 76
19 Essilor International Company Profile 77
19.1 Company Overview 77
19.2 Value Chain Analysis 77
19.2.1 Manufacturing 78
19.2.2 Product Development 78
19.2.3 Sales and Marketing 78
20 Johnson & Johnson Vision Care, Inc. Company Profile 79
20.1 Company Overview 79
21 Financial Deals Landscape 80
21.1 Acquisition 80
21.1.1 Essilor International Acquires Sinclair Optical Services 80
21.2 Private Equity 81
21.2.1 3i Acquires Ultralase From Corporacion Dermoestetica 81
21.2.2 Luxottica Group Signs An Agreement With Burberry Group 83
22 Recent Developments 85
22.1 Government and Public Interest 85
22.1.1 Jun 30, 2008: Microscopic Needles Could Revolutionise Eye Treatment 85
22.2 Strategy and Business Planning 85
22.2.1 May 15, 2008: Sauflon Plans To Build HUF3 Billion Contact Lens Factory In Hungary 85
22.2.2 Oct 10, 2007: Optos Plans For European Expansion 86
23 Appendix 87
23.1 Global Markets Direct Research Methodology 87
23.2 Coverage 88
23.3 Secondary Research 88
23.4 Primary Research 89
23.5 Models 89
23.6 Forecasts 90
23.7 Expert Panels 90
23.8 Currency Conversion 91
23.9 Contact Us 92
23.10 Disclaimer 92

1.1 List of Tables
Table 1: Number of Doctor by Specialty in UK, 2003 - 2007 15
Table 2: Medical Device Approval Fee in UK, 2006 30
Table 3: United Kingdom, Medical Equipment Market Comparison 35
Table 4: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012 37
Table 5: Ophthalmic Devices, United Kingdom, Category Revenues ($ mn), 2000-2012 38
Table 6: Ophthalmic Devices Market, United Kingdom, Portfolio Analysis 39
Table 7: Ophthalmic Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007 40
Table 8: Ophthalmic Devices, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012 41
Table 9: Ophthalmic Devices, United Kingdom, Category Volume (Units), 2000-2012 42
Table 10: Ophthalmic Devices, United Kingdom, Category Volume (Units), Historic, 2000-2007 42
Table 11: Ophthalmic Devices, United Kingdom, Category Volume (Units), Forecast, 2007-2012 42
Table 12: Ophthalmic Devices, United Kingdom, Overall Company Share by Revenue, 2006-2007 43
Table 13: Vision Care, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 45
Table 14: Vision Care, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Table 15: Vision Care, United Kingdom, Volume (Units) by Segment, Historic, 2000-2007 47
Table 16: Vision Care, United Kingdom, Volume (Units) by Segment, Forecast, 2007-2012 47
Table 17: Vision Care, United Kingdom, Average Price ($), Historic, 2000-2007 48
Table 18: Vision Care, United Kingdom, Average Price ($), Forecast, 2007-20012 48
Table 19: Vision Care, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007 49
Table 20: Vision Care, United Kingdom, Company Share by Revenue ($ mn), 2006-2007 50
Table 21: Cataract Surgery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 51
Table 22: Cataract Surgery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 52
Table 23: Cataract Surgery, United Kingdom, Volume (Units) by Segment, Historic, 2000-2007 53
Table 24: Cataract Surgery, United Kingdom, Volume (Units) by Segment, Forecast, 2007-2012 53
Table 25: Cataract Surgery, United Kingdom, Average Price ($), Historic, 2000-2007 54
Table 26: Cataract Surgery, United Kingdom, Average Price ($), Forecast, 2007-2012 54
Table 27: Cataract Surgery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007 55
Table 28: Cataract Surgery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007 56
Table 29: Refractive Surgery, United Kingdom, Revenues ($ mn), Historic, 2000-2007 57
Table 30: Refractive Surgery, United Kingdom, Revenues ($ mn), Forecast, 2007-2012 58
Table 31: Refractive Surgery, United Kingdom, Volume (Units), Historic, 2000-2007 59
Table 32: Refractive Surgery, United Kingdom, Volume (Units), Forecast, 2007-2012 60
Table 33: Refractive Surgery, United Kingdom, Average Price ($), Historic, 2000-2007 61
Table 34: Refractive Surgery, United Kingdom, Average Price ($), Forecast, 2007-2012 61
Table 35: Refractive Surgery, United Kingdom, Distribution Share by Revenue ($ mn), 2006-2007 62
Table 36: Refractive Surgery, United Kingdom, Company Share by Revenue ($ mn), 2006-2007 63
Table 37: Alcon, Inc. Pipeline Products by Equipment Type 67
Table 38: Alcon, Inc. Pipeline Products By Development Stage 67
Table 39: Alcon, Inc. Pipeline Products By Therapy Area 67
Table 40: Alcon, Inc. Pipeline Products By Clinical Trials 68
Table 41: Bausch & Lomb Incorporated Pipeline Products by Equipment Type 73
Table 42: Bausch & Lomb Incorporated Pipeline Products By Development Stage 73
Table 43: Bausch & Lomb Incorporated Pipeline Products By Therapy Area 73
Table 44: Bausch & Lomb Incorporated Pipeline Products By Clinical Trials 74
Table 45: Bausch & Lomb Incorporated Pipeline Products By News Summaries 74
Table 46: CIBA Vision Corporation Pipeline Products by Equipment Type 76
Table 47: CIBA Vision Corporation Pipeline Products By Development Stage 76
Table 48: CIBA Vision Corporation Pipeline Products By Therapy Area 76
Table 49: CIBA Vision Corporation Pipeline Products By Clinical Trials 76
Table 50: Currency Conversion from USD to Local Currency at 2007 Constant Rate 91

1.2 List of Figures
Figure 1: Total Healthcare Expenditure in UK, 2000 - 2006 14
Figure 2: Flowchart for Classification of Non-invasive Devices in UK, 2007 18
Figure 3: Flowchart for Classification of Invasive Devices in UK, 2007 19
Figure 4: Flowchart for Classification of Invasive Devices in UK, 2007 20
Figure 5: Flowchart for Classification of Invasive Devices in UK, 2007 21
Figure 6: Flowchart for Classification of Invasive Devices in UK, 2007 22
Figure 7: Flowchart for Classification of Active Devices in UK, 2007 23
Figure 8: Flowchart for Classification of Active Devices in UK, 2007 24
Figure 9: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in UK, 2007 25
Figure 10: Conformity Assessment of Class-I Medical Devices in UK, 2007 26
Figure 11: Conformity Assessment of Class-IIa Medical Devices in UK, 2007 27
Figure 12: Conformity Assessment of Class-IIb Medical Devices in UK, 2007 28
Figure 13: Conformity Assessment of Class-III Medical Devices in UK, 2007 29
Figure 14: United Kingdom, Medical Equipment Market Comparison, 2007 34
Figure 15: Ophthalmic Devices, Revenues ($ mn) by Country, 2000-2012 36
Figure 16: Ophthalmic Devices Market, Country Comparison 37
Figure 17: Ophthalmic Devices, United Kingdom, Category Revenues ($ mn), 2000-2012 38
Figure 18: Ophthalmic Devices Market, United Kingdom, Portfolio Analysis 39
Figure 19: Ophthalmic Devices, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007 40
Figure 20: Ophthalmic Devices, United Kingdom, Category Revenues ($ mn), Forecast, 2007-2012 41
Figure 21: Ophthalmic Devices, United Kingdom, Overall Company Share (%), 2007 43
Figure 22: Vision Care, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 44
Figure 23: Vision Care, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 24: Vision Care, United Kingdom, Company Share (%), 2007 50
Figure 25: Cataract Surgery, United Kingdom, Revenue ($ mn) by Segment, Historic, 2000-2007 51
Figure 26: Cataract Surgery, United Kingdom, Revenue ($ mn) by Segment, Forecast, 2007-2012 52
Figure 27: Cataract Surgery, United Kingdom, Company Share (%), 2007 56
Figure 28: Refractive Surgery, United Kingdom, Revenues ($ mn), Historic, 2000-2007 57
Figure 29: Refractive Surgery, United Kingdom, Revenues ($ mn), Forecast, 2007-2012 58
Figure 30: Refractive Surgery, United Kingdom, Volume (Units), Historic, 2000-2007 59
Figure 31: Refractive Surgery, United Kingdom, Volume (Units), Forecast, 2007-2012 60
Figure 32: Refractive Surgery, United Kingdom, Company Share (%), 2007 63
Figure 33: Alcon, Inc., Value Chain Analysis 64
Figure 34: Bausch & Lomb Incorporated, Value Chain Analysis 70
Figure 35: Essilor International, Value Chain Analysis 77
Figure 36: Global Markets Direct Methodology 87